Overseas Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 06-12-2024
- Paid Up Capital ₹ 2.50 M
as on 06-12-2024
- Company Age 65 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.20 M
as on 06-12-2024
- Revenue 10744.90%
(FY 2023)
- Profit 3543.07%
(FY 2023)
- Ebitda 5690.29%
(FY 2023)
- Net Worth 16116.63%
(FY 2023)
- Total Assets 13653.50%
(FY 2023)
About Overseas Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹2.20 M.
Nerendranath Venkatachala, Thimmaiah Gowda, Manjula Krishnappa, and One other member serve as directors at the Company.
- CIN/LLPIN
U24119KA1959PTC001361
- Company No.
001361
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 1959
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Overseas Pharma Private Limited offer?
Overseas Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Sarees, Lehenga and Salwar Suits, Indian Sarees, Thyroxine Sodium Tablets, Skin Ointment.
Who are the key members and board of directors at Overseas Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Untagodu Pavithra  | Director | 16-Jan-2017 | Current |
| Nerendranath Venkatachala | Director | 16-Jan-2017 | Current |
| Thimmaiah Gowda | Director | 05-Jan-2017 | Current |
| Manjula Krishnappa | Director | 16-Jan-2017 | Current |
Financial Performance and Corporate Structure Insights of Overseas Pharma.
Overseas Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10744.9% increase. The company also saw a substantial improvement in profitability, with a 3543.07% increase in profit. The company's net worth Soared by an impressive increase of 16116.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Overseas Pharma?
Unlock access to Overseas Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dr. Ramesh Cardiac And Multispeciality Hospital Private LimitedActive 29 years 6 monthsNerendranath Venkatachala is a mutual person
Medisync Health Management Services Private LimitedActive 6 years 4 monthsNerendranath Venkatachala is a mutual person
Vertexhealth Comprehensive Health Servic Es LlpActive 6 years 5 monthsNerendranath Venkatachala is a mutual person
- Hindustan Pharma Distributors Private LimitedActive 3 years 4 months
Nerendranath Venkatachala is a mutual person
- Sri Naga Sai Healthcare Private LimitedActive 13 years 6 months
Nerendranath Venkatachala is a mutual person
- Disease Management Association Of IndiaActive 2 years 9 months
Nerendranath Venkatachala is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 15 Feb 2021 | ₹2.20 M | Open |
How Many Employees Work at Overseas Pharma?
Overseas Pharma has a workforce of 9 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Overseas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Overseas Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
